Combination therapy using nucleic acids and radio therapy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C536S023100

Reexamination Certificate

active

06841538

ABSTRACT:
The present invention relates to methods for increasing the efficiency of transformation of cycling cells, the methods comprising synchronizing cells at a first stage of the cell cycle, and transforming the cells at a second stage of the cell cycle within about one cell cycle of the first stage with a genetically engineered nucleic acid that encodes a desired gene product. The invention further relates to cancer therapy and, in particular, to methods of efficiently transforming cancer cells with nucleic acids that encode gene products that inhibit the growth of cancer cells.

REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 5571797 (1996-11-01), Ohno et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5591601 (1997-01-01), Wagner et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5688773 (1997-11-01), Chiocca et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5747469 (1998-05-01), Roth et al.
patent: 5888735 (1999-03-01), Vogelstein et al.
patent: 0 760 675 (1997-03-01), None
patent: 1548621 (1979-07-01), None
patent: WO 9207943 (1992-05-01), None
patent: WO 9400095 (1994-01-01), None
patent: WO 9508994 (1995-04-01), None
patent: WO 9640964 (1996-12-01), None
patent: WO 9641875 (1996-12-01), None
Bernhard et al. Radiat Environ Biophys 34:79-83 (1995).*
Hwang et al. Radiatio Research 150(Suppl.)S52-S59 (1998).*
Rieder et al. JCB 142(4):1013-1022 (Aug. 1998).*
Mikkelsen et al. Radiat Res 132(2) (Nov. 1992).*
Giancoli, PHYSICS Principles with Applications, Third Edition, p. 579.*
Serway, PHYSICS for Scitistts & Engineers, 2nd Edition, pp. 786-787.*
Son et al. Proceedings from the National Academy of Science 91:12669-12672, Dec. 1994.*
Spang-Thomsen et al. European Journal of Cancer and Clinical Oncology 20(6):849-855, 1984.*
Yorifuji et al. FEBS Letters 245(1-2):201-203, Mar. 1989.*
Cohen,Immunol. Today, 14(3):126-130 (1993).
Gavriel, et al.,J. Cell Biol., 119(3):493-501 (1992).
Lunardi-Iskandar, et al.,Clin. Exp. Immunol., 60:285-293 (1985).
Son, et al.,Proc. Natl. Acad. Sci. USA, 91:12669-12672 (1994).
White, et al.,J. Virol., 52(2):410-419 (1984).
Brigham, et al.,Am. J. Med. Sci., 298(4):278-281 (1989).
Cone, et al.,Proc. Natl. Acad. Sci. USA, 81:6349-6353 (1984).
Eglitis, et al.,BioTEchniques, 6(7):608-614 (1988).
Gilboa, et al.,BioTechniques, 4(6):504-512 (1986).
Hyde, et al,Nature, 362:250-256 (1993).
Ikegami, et al.,Nature, 275:458-460 (1978).
Keyomarsi, et al.,Cancer Research, 51:3602-3609 (1991).
Legendre, et al.,Pharmaceutical Research, 9(10):1235-1242 (1992).
Mann, et al.,Cell, 33:153-159 (1983).
Miller, et al.,BioTechniques, 7(9):981-990 (1989).
Peters,Nature, 371:204-205 (1994).
Sherr,Cell, 73:1059-1065 (1993).
Tseng, et al.,Biotechnology and Bioengineering, 50:548-554 (1996).
Wahl, et al.,Biochemistry, 25:7821-7827 (1986).
Zabner, et al.,J. Biol. Chem., 270(32):18997-19007 (1995).
Zhu, et al.,Science, 261:209-211 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy using nucleic acids and radio therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy using nucleic acids and radio therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using nucleic acids and radio therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3400228

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.